Franklin Resources
CRL icon

Franklin Resources’s Charles River Laboratories CRL Stock Holding History

Franklin Resources’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7M Sell
104,598
-16,230
-13% -$2.89M 0.01% 957
2026
Q1 		$20.8M Sell
120,828
-55
-0% -$10.2K 0.01% 973
2025
Q4 		$24.1M Buy
120,883
+92,217
+322% +$16.7M 0.01% 899
2025
Q3 		$4.49M Sell
28,666
-196,934
-87% -$31.3M ﹤0.01% 1460
2025
Q2 		$34.2M Sell
225,600
-272,199
-55% -$36.3M 0.01% 752
2025
Q1 		$74.9M Sell
497,799
-149,981
-23% -$25.1M 0.02% 474
2024
Q4 		$120M Sell
647,780
-16,675
-3% -$3.21M 0.03% 406
2024
Q3 		$128M Sell
664,455
-693
-0.1% -$144K 0.04% 386
2024
Q2 		$137M Buy
665,148
+13,343
+2% +$3.02M 0.04% 342
2024
Q1 		$177M Sell
651,805
-111,210
-15% -$26.6M 0.06% 304
2023
Q4 		$180M Sell
763,015
-18,486
-2% -$3.64M 0.08% 256
2023
Q3 		$153M Buy
781,501
+56,248
+8% +$11.5M 0.08% 273
2023
Q2 		$152M Sell
725,253
-934
-0.1% -$186K 0.07% 298
2023
Q1 		$147M Buy
726,187
+30,975
+4% +$7.02M 0.07% 300
2022
Q4 		$151M Buy
695,212
+50,044
+8% +$10.9M 0.08% 289
2022
Q3 		$127M Buy
645,168
+222,387
+53% +$48M 0.07% 324
2022
Q2 		$90.5M Buy
422,781
+4,496
+1% +$1.1M 0.04% 404
2022
Q1 		$119M Sell
418,285
-74,628
-15% -$23M 0.05% 395
2021
Q4 		$186M Buy
492,913
+70,113
+17% +$27.2M 0.07% 318
2021
Q3 		$174M Buy
422,800
+40,732
+11% +$16.9M 0.07% 326
2021
Q2 		$141M Buy
382,068
+9,073
+2% +$3.03M 0.05% 378
2021
Q1 		$108M Buy
372,995
+15,534
+4% +$4.32M 0.04% 417
2020
Q4 		$89.3M Buy
357,461
+219,383
+159% +$52.2M 0.04% 451
2020
Q3 		$31.3M Buy
+138,078
New +$28.7M 0.02% 667
2020
Q2 		– Sell
-101,455
Closed -$12.8M – 1695
2020
Q1 		$12.8M Buy
+101,455
New +$15.2M 0.01% 762
2019
Q4 		– Sell
-14,259
Closed -$1.89M – 1538
2019
Q3 		$1.89M Buy
14,259
+10,106
+243% +$1.35M ﹤0.01% 1177
2019
Q2 		$589K Buy
+4,153
New +$563K ﹤0.01% 1349

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Franklin Resources's CRL Position: Q2 2026 in Review

Franklin Resources reduced its Charles River Laboratories (CRL) stake by 13% in Q2 2026, selling an estimated $2.89M and leaving 104,598 shares worth $23.7M. The position accounts for 0.01% of the portfolio, ranked #957.

Franklin Resources first reported a position in CRL in Q2 2019 and has held it in 27 quarters since. The position peaked at $186M in Q4 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Franklin Resources held 104,598 shares of Charles River Laboratories worth $23.7M as of Q2 2026.
  • Franklin Resources sold 16,230 Charles River Laboratories shares in Q2 2026, an estimated $2.89M.
  • Charles River Laboratories made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #957 holding.
  • Franklin Resources first reported a position in Charles River Laboratories in Q2 2019 and has held it in 27 quarters since.
  • Franklin Resources's Charles River Laboratories position peaked at $186M in Q4 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.